Levodopa nanoencapsulation in nanostarch as anti-parkinsonian drugs candidate

Levodopa nanoencapsulation in nanostarch as anti-parkinsonian drugs candidate

Parkinson's disease is caused by damage to the dopaminergic nerves in brain. Levodopa has been widely used to treat Parkinson's disease. The levodopa nano encapsulation aims to improve drug-delivery efficiency thereby increasing the concentration of released levodopa in the brain. This stu...

Full description

Bibliographic Details
Main Authors: Sardjono, Ratnaningsih Eko, Dhea, Salsabila, Gunawan, Ramdhan, Kadarohman, Asep, Budiman, Anwar, Vidia Afina, Nuraini, Erdiwansyah, ., Rizalman, Mamat, Fitri, Dara, Melati, Khairuddean
Format: Article
Language:English
Published: Scientific Publishers 2023
Subjects:
RC Internal medicine
TJ Mechanical engineering and machinery
Online Access:https://umpir.ump.edu.my/id/eprint/44265/

Internet

https://umpir.ump.edu.my/id/eprint/44265/

Similar Items